Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × HER2-negative Breast Cancer × Clear all

Status

Sponsor Class

Study Type

Interventional 9 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2447 Neoplasms 2210 Lung Neoplasms 1120 Colorectal Neoplasms 1104 Prostatic Neoplasms 1029 Carcinoma, Non-Small-Cell Lung 895 Carcinoma, Hepatocellular 648 Stomach Neoplasms 604 Pancreatic Neoplasms 584 Ovarian Neoplasms 481 Colonic Neoplasms 436 Uterine Cervical Neoplasms 410 Head and Neck Neoplasms 404 Rectal Neoplasms 393 Melanoma 393 Multiple Myeloma 392 Esophageal Neoplasms 362 Neoplasm Metastasis 354 Brain Neoplasms 344 Urinary Bladder Neoplasms 329 Lymphoma 321 Precursor Cell Lymphoblastic Leukemia-Lymphoma 316 Leukemia, Myeloid, Acute 306 Carcinoma, Renal Cell 283 Leukemia 276 Hematologic Neoplasms 267 Endometrial Neoplasms 261 Liver Neoplasms 259 Recurrence 241 Glioma 225

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05334147 2022-04-19

ALOT-BC1

The First Affiliated Hospital with Nanjing Medical University

HER2-negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡